ROIV ROIVW - JAMA Dermatology Publishes Skin-Specific Outcomes from Phase 3 VALOR Trial Of Brepocitinib in Dermatomyositis - Click For Relea
ROIV ROIVW - JAMA Dermatology Publishes Skin-Specific Outcomes from Phase 3 VALOR Trial Of Brepocitinib in Dermatomyositis
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.